Selection analyses of paired HIV-1 gag and gp41 sequences obtained before and after antiretroviral therapy.

ABSTRACT: Most HIV-1-infected individuals with virological failure on a pharmacologically-boosted protease inhibitor (PI) regimen do not develop PI-resistance protease mutations. One proposed explanation is that HIV-1 gag or gp41 cytoplasmic domain mutations might also reduce PI susceptibility. In a recent study of paired gag and gp41 sequences from individuals with virological failure on a PI regimen, we did not identify PI-selected mutations and concluded that if such mutations existed, larger numbers of paired sequences from multiple studies would be needed for their identification. In this study, we generated site-specific amino acid profiles using gag and gp41 published sequences from 5,338 and 4,242 ART-naïve individuals, respectively, to assist researchers identify unusual mutations arising d

SUBMITTER: Tzou PL 

PROVIDER: S-EPMC6057438 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature